drugset / Trial / NCT01210521

Use of Vitamin D3 for the Treatment of Steroid Resistant Asthmatic Patients

NCT01210521

Phase 2 Withdrawn Florida Atlantic University
Non-randomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to determine the effects of vitamin D3 on severe asthmatic patients. Vitamin D3 may alter the response of these patients to conventional steroid therapy, making them more responsive to the latter form of treatment. Patients will be treated daily with an oral dose (2,000 IU) of vitamin D3 for one month and their clinical and serological parameters, and immune function, will be evaluated. Results from pre- and post-vitaminD3 treatment will be compared.

Timeline

Start
2010-09
Primary completion
2016-02
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Vitamin D Other / unclassified 2000 iu Oral

Indications